Discontinuation of RAAS Inhibition in Children with Advanced CKD

van den Belt, SM; Heerspink, HJL; Kirchner, M; Gracchi, V; Thurn-Valsassina, D; Bayazit, AK; Niemirska, A; Canpolat, N; Bulut, IK; Azukaitis, K; Duzova, A; Bacchetta, J; Shroff, R; Paripovic, D; Ozcakar, ZB; Fidan, K; Erdogan, H; Gellermann, J; Wuhl, E; de Zeeuw, D; Melk, A; Querfeld, U; Schaefer, F

van den Belt, SM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.; van den Belt, SM (corresponding author), Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Hanzepl 1 HPC EB70,POB 30 001, NL-9700 RB Groningen, Netherlands.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020; 15 (5): 625

Abstract

Background and objectives Although renin-angiotensin-aldosterone system inhibition (RAASi) is a cornerstone in the treatment of children with CKD, it ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索